Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Jenning V and Gohla SH Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul pmid:11253932
pmid:
Chi N et al. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer. Pharm Dev Technol pmid:19671037
Perez MA et al. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix. 1993 P R Health Sci J pmid:8140204
zur Mühlen A et al. Atomic force microscopy studies of solid lipid nanoparticles. 1996 Pharm. Res. pmid:8893284
Iloañusi NO and Schwartz JB The effect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization. 1998 Drug Dev Ind Pharm pmid:15605595
Barthelemy P et al. Compritol 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulations. 1999 Eur J Pharm Biopharm pmid:10234531
Freitas C and Müller RH Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. 1999 Jan-Feb J Microencapsul pmid:9972503
Schöler N et al. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. 2000 Int J Pharm pmid:10699726
Jenning V et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. 2000 Eur J Pharm Biopharm pmid:10799811
Faham A et al. Hot melt coating technology: influence of Compritol 888 Ato and granule size on chloroquine release. 2000 Pharmazie pmid:10907253
Mirghani A et al. Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. 2000 Drug Dev Ind Pharm pmid:10872101
Faham A et al. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. 2000 Drug Dev Ind Pharm pmid:10697753
Obaidat AA and Obaidat RM Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. 2001 Eur J Pharm Biopharm pmid:11522491
Hamdani J et al. Development and evaluation of prolonged release pellets obtained by the melt pelletization process. 2002 Int J Pharm pmid:12270253
N'Diaye A et al. Comparative study of the lubricant performance of Compritol HD5 ATO and Compritol 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. 2003 Int J Pharm pmid:12623202
Hamdani J et al. Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. 2003 Int J Pharm pmid:12818809
Zhang YE and Schwartz JB Melt granulation and heat treatment for wax matrix-controlled drug release. 2003 Drug Dev Ind Pharm pmid:12648009
Jannin V et al. Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating. 2003 Int J Pharm pmid:12927386
Gu X et al. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. 2004 Drug Dev Ind Pharm pmid:15595567
Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate. 2004 Int. J. Toxicol. pmid:15513825
Hariharan M et al. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. 2004 Drug Dev Ind Pharm pmid:15285329
Jores K et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. 2004 J Control Release pmid:14980770
Gavini E et al. Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies. 2005 Pharm Dev Technol pmid:16370177
He J et al. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16400939
Souto EB and Müller RH SLN and NLC for topical delivery of ketoconazole. 2005 J Microencapsul pmid:16361193
Lombardi Borgia S et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. 2005 J Control Release pmid:16297487
Quintanar-Guerrero D et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. 2005 Eur J Pharm Sci pmid:16046105
Hu LD et al. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. 2005 Yao Xue Xue Bao pmid:15881775
Turkoglu M et al. Evaluation of hexagonal boron nitride as a new tablet lubricant. 2005 Pharm Dev Technol pmid:16176018
Jores K et al. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. 2005 Pharm. Res. pmid:16132349
Videira MA et al. Lymphatic uptake of lipid nanoparticles following endotracheal administration. 2006 J Microencapsul pmid:17390627
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Souto EB et al. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. 2006 J Microencapsul pmid:16854817
Hamdani J et al. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. 2006 Int J Pharm pmid:16824707
Li FQ et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. 2006 Int J Pharm pmid:16837152
Hamdani J et al. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. 2006 Int J Pharm pmid:16815656
Furlanetto S et al. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. 2006 Eur J Pharm Biopharm pmid:16154333
Castro GA et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. 2007 J Microencapsul pmid:17578730
Tursilli R et al. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. 2007 Eur J Pharm Biopharm pmid:17407809
Hou DZ et al. [Microstructure of novel solid lipid nanoparticle loaded triptolide]. 2007 Yao Xue Xue Bao pmid:17633214
Chen G et al. [Preliminary study on brain-targeted drug delivery via inner ear]. 2007 Yao Xue Xue Bao pmid:18229622
Ozyazici M et al. In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules. 2007 Pharm Dev Technol pmid:18161631
Thakkar H et al. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. 2007 Drugs R D pmid:17767393
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840
Brubach JB et al. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. 2007 Int J Pharm pmid:17207945
Ghimire M et al. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog. 2007 Eur J Pharm Biopharm pmid:17498934
Montana G et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. 2007 Mar-Apr Bioconjug. Chem. pmid:17253655
Sengel-Türk CT et al. Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris. 2008 J Microencapsul pmid:18465309
Dalpiaz A et al. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine. 2008 Int J Pharm pmid:18178347